Morphology and chromosomes of Tatera Lataste 1882 (Rodentia Muridae Gerbillinae) in West Africa

In a sample of the genus Tatera Lataste 1882 from West Africa (Benin and Burkina Faso), we analyzed the cranial and dental morphology and the karyotype (G, R, C and NOR banding). The cranial morphology confirms the attribution of this sample to Tatera kempi Wroughton 1906. An analysis of the dental morphology was also performed but it seems not to offer diagnostic traits. The karyotype described in the present work for T. kempi is comparable with that described for T. hopkinsoni Thomas 1911, supporting the synonymy of these two taxa. In contrast, the karyological results clearly discriminate kempi from both guineae and nigrita, the latter currently considered a synonym. In the karyotype of T. kempi, we found a polymorphism of a small chromosome, which occurs in the three situations: metacentric/metacentric, metacentric/acrocentric and acrocentric/ acrocentric. A similar polymorphism was described for hopkinsoni. The banding shows that the variation of the morphology of the X chromosome in Tatera is related to a pericentric inversion. KEY WORDS: Tatera, rodents, chromosomes, taxonomy, West Africa, evolution

Bloodborne Viral Hepatitis Infections among Drug Users: The Role of Vaccination

Drug use is a prevalent world-wide phenomenon and hepatitis virus infections are traditionally a major health problem among drug users (DUs). HBV and HCV, and to a lesser extent HAV, are easily transmitted through exposure to infected blood and body fluids. Viral hepatitis is not inevitable for DUs. Licensed vaccines are available for hepatitis A and hepatitis B. The purpose of this overview is to show some epidemiological data about HBV and the other blood-borne viral hepatitis among DUs and to summarize and discuss use of hepatitis vaccinations in this population. Successful vaccination campaigns among DUs are feasible and well described. We try to focus on the most significant results achieved in successful vaccination programs as reported in scientific literature. Vaccination campaigns among DUs represent a highly effective form of health education and they are cost-saving

Small intestine contrast ultrasonography in pediatric Crohn's disease.

Objective To evaluate the diagnostic accuracy of small intestine contrast ultrasonography (SICUS) in pediatric Crohn's disease (CD). Study design A total of 51 consecutive patients (median age 15 years; range 3-20, 31 male patients), 21 with suspected and 30 with proven CD, were studied. All patients underwent standard ultrasonography (ie, transabdominal ultrasonography [TUS]), SICUS, small bowel follow-through, and upper and lower endoscopy. SICUS was performed in patients after they ingested an oral contrast solution. TUS and SICUS were compared with small bowel follow-through and endoscopy via use of the final diagnosis as reference standard. Results In undiagnosed patients, the sensitivity and specificity of TUS and SICUS in detecting CD small bowel lesions were 75% and 100% and 100% and 100%, respectively. In patients with proven CD, the sensitivity and specificity of TUS and SICUS were 76% and 100% and 96% and 100%, respectively. The agreement (k) with radiology for site of lesions was almost perfect for SICUS (0.93), both for jejunal and ileal lesions, and it was fair (0.40) for jejunal and substantial (0.68) for ileal lesions for TUS. Compared with radiology SICUS correctly assessed the length of lesions, whereas TUS underestimated it (P = .0001). Conclusions The radiation-free technique SICUS is comparable with radiology and more accurate than TUS in assessing small bowel lesions in pediatric CD, mainly in the detection of proximal small bowel disease

Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial.

Background: :Endoscopic balloon dilation (EBD) is an attractive conservative therapy for Crohn's disease (CD) with stricture; however, its long-term efficacy has been questioned because many patients require more dilations or postdilation surgery. Most reports are retrospective, and no pediatric data are available. Objective: To assess the effectiveness of corticosteroid intralesional injection after EBD in preventing stricture recurrence. Design: Single-center prospective, randomized, double-blind, controlled trial. Setting: Tertiary-referral university hospital. Patients: Between November 2005 and January 2009, 29 pediatric patients with stricturing CD were enrolled. Interventions: Enrolled patients were randomized to receive intrastricture injection of corticosteroid (CS) (n = 15) or placebo (n = 14) after EBD. Patients were followed clinically via small intestine contrast US and intestinal magnetic resonance imaging at 1, 3, 6, and 12 months; all underwent colonoscopy 12 months after dilation. Main Outcome Measurements: Time free of repeat dilation and time free of surgery in the 2 groups. Results: One of the 15 patients receiving CS required redilation, whereas the latter was needed in 5 of the 14 placebo patients; surgery was needed in 4 of the placebo patients, but in none of those receiving CS. The 2 groups statistically differed in the time free of redilation (P = .04) as well as for time free of surgery after EBD (P = .02), which were worse in the placebo group compared with the CS group. There were no significant differences in baseline demographics between the 2 groups. Limitations: Sample size, participation bias, and short-term follow-up. Conclusion: In pediatric CD with stricture, intralesional CS injection after EBD is an effective strategy for reducing the need both for redilation and surgery. (Gastrointest Enclose 2010;72:1201-8.

Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group

Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activities after COVID-19 peak in Italy